Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
aneurysm
aneurysm, intracranial
aneurysm, intracranial, treatment of
antifibrinolytic drugs
CAT scan, abnormal
CAT scan, angiography
cerebral ischemia
cerebrovascular accident, acute management of
complications
controversies in neurology
CRASH-3
delirium
disability, neurological
epistaxis
epsilon-aminocaproic acid(E.A.C.A.)
Glasgow coma score
head injury
head injury, management of
head injury, severe
hemostatic therapy
hereditary hemorrhagic telangiectasia(HHT)
hydrocephalus
iatrogenic neurologic disorders
intracerebral hemorrhage
intracerebral hemorrhage, clot evacuation
intracerebral hemorrhage, progression of
intracerebral hemorrhage, treatment of
mortality
recombinant activated factor VII
review article
risk factors
seizure
seizure, drug-induced
Spot sign
subarachnoid hemorrhage
subarachnoid hemorrhage, prognosis
subarachnoid hemorrhage, treatment of
tranexamic acid
trauma
treatment of neurologic disorder
ventriculostomy
Showing articles 0 to 50 of 1131 Next >>

Tranexamic Acid Within 4.5 Hours of Intracerebral Hemorrhage With the CTA Spot Sign, Systematic Review and Individual Patient Meta-Analysis
Neurol 103:e210104, Yassi,N.,et al, 2024

Out-of-Hospital Tranexamic Acid for Traumatic Brain Injury
JAMA 324:946-947, Cone, D.C.,et al, 2020

Effects of Tranexamic Acid on Death, Disability, Vascular Occlusive Events and Other Morbidities in Patients with Acute Traumatic Brain Injury (CRASH-3): A Randomised, Placebo-Controlled Trial
Lancet 394:1713-1723,1687, The CRASH-3 trial collaborators, 2019

Intracerebral Haemorrhage: Current Approaches to Acute Management
Lancet 392:1257-1268, Cordonnier, C.,et al, 2018

Tranexamic Acid-Associated Seizures: Causes and Treatment
Ann Neurol 79:18-26, Lecker, I.,et al, 2016

Antifibrinolytic Therapy for Aneurysmal Subarachnoid Hemorrhage, A Major Update of a Cochrane Review
Stroke 34:2308-2309, Roos,Y.,et al, 2003

Tranexamic Acid in Hereditary Hemorrhagic Telangiectasia
NEJM 346:457, Sabra,C.,et al, 2002

Antifibrinolytic Treatment in Subarachnoid Hemorrhage, A Randomized Placebo-Controlled Trial
Neurol 54:77-82, Roos,Y.,STAR Study Group, 2000

Antifibrinolytics in Subarachnoid Hemorrhage, Do They Have a Role? No
Arch Neurol 44:116-118, Weir,B., 1987

Antifibrinolytics in Aneurysmal Subarachnoid Hemorrhage, Do They Have a Role? Maybe
Arch Neurol 44:114-115, 1181987., Adams,H.P., 1987

Antifibrinolytic Treatment in Subarachnoid Hemorrhage
NEJM 311:432-437, Vermeulen,M.,et al, 1984

Antifibrinolytic Therapy in Patients With Aneurysmal Subarachnoid Hemorrhage
Jr. , et al, Arch Neurol 38:25-2981., Adams,H.P., 1981

Antifibrinolytic Therapy in Subarachnoid Hemorrhage Caused by Ruptured Intracranial Aneurysm
Neurol 31:316-322, Ramirez-Lassepas,M., 1981

Treatment of Subarachnoid Hemorrhage from Ruptured Intracranial Aneurysm with Tranexamic Acid:A Double-blind Clinical Trial
Ann Neurol 3:502, Chandra,B., 1978

Effect of Tranexamic Acid on Rebleeding after Subarachnoid Hemorrhage:A Double-blind Controlled Clinical Trial
Ann Neurol 2:242, vanRossum,J.,et al, 1977

Vitamin B12 Deficiency:NICE Guideline Summary
BMJ 385:q1019, q1262, Sands,T.,et al, 2024

Apixaban vs Aspirin in Patients with Cancer and Cryptogenic Stroke A Post Hoc Analysis of the ARCADIA Randomized Clinical Trial
JAMA Neurol 81:957-965, Navi,B.B.,et al, 2024

Progressive Cervical Osteophytosis and Dysphagia Associated with Isotretinoin Treatment for Rosacea
Lancet 404:e4, Naraghi,K. & Marzo-Ortega,H., 2024

Glial Fibrillary Acidic Protein Astrocytopathy:Review of Pathogenesis, Imaging Features, and Radiographic Mimics
AJNR 45:1394-1402, Shetty,D.,et al, 2024

Anticoagulation vs Antiplatelets Across Subgroups of Embolic Stroke of Undetermined Source
Neurol 103:e209949, Grannam,M.,et al, 2024

Recurrent Rhombencephalitis Associatedwith Anti-GAD65 Antibody
Neurol 102:e208040, Alferes,A.R.,et al, 2024

Partially Reversible FLAIR Hyperintensity Along the Brainstem Surface in Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy
Neurol 102:e208064, Wu, J.,et al, 2024

Apixaban to Prevent Recurrence After Cryptogenic Stroke in Patients with Atrial Cardiopathy, The ARCADIA Randomized Clinical Trial
JAMA 331:573-581, Kamel,H.,et al, 2024

Posttransplant Anti-GABAA Receptor Antibody-Associated Autoimmune Encephalitis
Neurol 102:e209245, Togni,C.L.,et al, 2024

Anti-NMDA Receptor Encephalitis Presenting with Cerebellitis in a Pediatric Patient
Neurol 102:e209259, Moehlman,M. & Kornbluh,A.B., 2024

Clinicopathological Conference, Glutamic Acid Decarborylase 65 Autoantibody-Associated Stiff-Person Syndrome
NEJM 390:1712-1719, Case 14-2024, 2024

Neurocysticercosis School Outbreak in Belgium
Lancet 404:2415-2416, Vanden Driessche,K., et al, 2024

Cerebrovascular Events in Patients Undergoing Transcatheter Aortic Valve Replacement:A Review
Stroke 55:2754-2764, Patel,K.P.,et al, 2024

A 65-Year-Old Woman with Isolated Macroglossia as the Initial Presentation of a Rare Disease
Neurol 103:e210070, Lara,C.,et al, 2024

2024 Guide for the Primary Prevention of Stroke:A Guideline From the American Heart Association/American Stroke Association
Stroke 55:e344-e424, Bushnell,C.,et al, 2024

Overlapping Anti-NMDAR Encephalitis and Multiple Sclerosis: A Case Report and Literature Review
Front Immunol doi:10.3389/Fimmun.2023.1088801, Liu,P.,et al, 2023

A Young Adult Man with Cognitive Changes, Gait Difficulty, and Renal Insufficiency
Neurol 100:206-212, Stamm,B.,et al, 2023

Cortical Superficial Siderosis and Transient Focal Neurological Episode Preceding Lobar Hemorrhage in Cerebral Amyloid Angiopathy
Stroke 54:e48-e51, Therdorou,A.,et al, 2023

Antithrombotic Therapy in Patients with Cerebral Microbleeds or Cortical Siderosis, Is This Contraindicated?
Neurol 100:551-552, Schneck,M.J., &Biller,J., 2023

Clinicopathologic Conference, Functional Vitamin B12 Deficiency from Use of Nitrous Oxide
NEJM 388:1893-1900, Case 15-2023, 2023

Adult Patient Presenting with Spine Pain Following a Motor Vehicle Accident
Neurol 100:1025-1031, Sharma,V. & Soto,O, 2023

Tirofiban for Stroke without Large or Medium-Sized Vessel Occlusion
NEJM 388:2025-2095, Zi,W.,et al, 2023

Severe Hippocampal Atrophy in a Patient with Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy
JAMA Neurol 80:642-643, Bartels,F.,et al, 2023

Antiplatelet Therapy or Not for Asymptomatic/Incidental Lacunar Infarction
Stroke 54:1954-1959, Bilski.A.,et al, 2023

Perioperative Management of Anticoagulant and Antiplatelet Therapy
NEJM Evid doi:10.1056/EVIDna2200322, Douketis,J.D. & Spyropoulos,A.C., 2023

Manganese Accumulation in the Brain
NEJM 389:1320, Sherman,S.V., 2023

Coagulation Factor Expression and Composition of Arterial Thrombi in Cancer-Associated Stroke
Stroke 54:2981-2989, Yoo,J.,et al, 2023

Dual Antiplatelet Treatment up to 72 Hours After Ischemic Stroke
NEJM 389:2413-2424, 2478, Gao,Y.et al, 2023

Oral and Topical Treatment of Painful Diabetic Polyneuropathy: Practice Guideline Update Summary
Neurol 98:31-43, Price, R.,et al, 2022

Linear Radial Brainstem Enhancement in Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy
JAMA Neurol 79:82-83, Mirian, A.,et al, 2022

Glial Fibrillary Acidic Protein Autoimmunity
Neurol 98:e653-e668, Gravier-Dumonceau, A.,et al, 2022

Bleeding Risk of Dual Antiplatelet Therapy after Minor Stroke or Transient Ischemic Attack
Ann Neurol 91:380-388, Wang, A.,et al, 2022

Stroke Prevention in Symptomatic Large Artery Intracranial Atherosclerosis Practice Advisory
Neurol 98:486-498, Turan, T.N.,et al, 2022

Spina Bifida
NEJM 387:444-450, Iskandar, B.J. & Finnell, R.H., 2022



Showing articles 0 to 50 of 1131 Next >>